MADISON, Wis. – A Madison stem cell company developing ways to screen drugs for side effects will receive $1 million in a grant and a loan from the state to help get started, Gov. Jim Doyle said Monday.
Stemina Biomarker Discovery, Inc., is trying to commercialize discoveries made by University of Wisconsin-Madison stem cell researcher Gabriela Cezar, the companyâ??s co-founder and chief scientific officer.
The company is trying to build a library of biomarkers to help companies screen drugs and drug candidates for potentially toxic side effects. Biomarkers are the signals that stem cells give off when exposed to a certain drug or disease.